Molecular biology studies in chronic myeloid leukemia
Cervantes, F.
Medicina Clinica 101(14): 538-540
1993
ISSN/ISBN: 0025-7753 PMID: 8231399 Document Number: 421279
Document emailed within 1 workday
Related Documents
Michalová, K.; Zemanová, Z.; Haskovec, C.; Rypácková, B.; Brdicka, R. 1992: Use of cytogenetic and molecular biology in the detection of chronic myeloid leukemia Casopis Lekaru Ceskych 131(24-25): 729-732Lo Coco, F.; Mandelli, F.; Diverio, D.; Alimena, G.; De Fabritiis, P.; Meloni, G.; Cedrone, M.; Frontani, M.; Guerrasio, A.; Saglio, G. 1990: Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusion Bone Marrow Transplantation 6(4): 253-258
Sasaki, K.; Mitani, K. 2009: Molecular pathogenesis of chronic myeloid leukemia Nihon Rinsho. Japanese Journal of Clinical Medicine 67(10): 1894-1899
Reed, J.C. 1998: Molecular biology of chronic lymphocytic leukemia Seminars in Oncology 25(1): 11-18
Tanzer, J. 1991: Molecular biology of chronic myelogenous leukemia Nouvelle Revue Francaise d'Hematologie 33(2): 197-200
Kajtár, B.él.; Méhes, G.áb.; Jaksó, P.ál.; Kereskai, L.ás.ó; Iványi, J.án.L.ás.ó; Losonczy, H.; Egyed, M.ós.; Tóth, P.ét.; Tóth, A.; Gasztonyi, Z.án.; Dömötör, M.ár.; Pajor, L.ás.ó 2006: Cytogenetic and molecular monitoring of chronic myeloid leukemia Orvosi Hetilap 147(21): 963-970
Sinkovics, J.; Horváth, J. 2001: Molecular biology investigations in chronic lymphocytic leukemia Orvosi Hetilap 142(42): 2338-2339
Jadayel, D.; Calabrese, G.; Min, T.; van Rhee, F.; Swansbury, G.J.; Dyer, M.J.; Maitland, J.; Palka, G.; Catovsky, D. 1995: Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation Leukemia 9(6): 981-987
Valiente, A.; Benítez, J.; Pérez Sáenz, M.A.; Sánchez Fayos, J. 1989: Molecular analysis in 13 cases of chronic Philadelphia-positive myeloid leukemia Sangre 34(6): 481-484
Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715
Larripa, I.; Ruiz, Mía.Sol.; Gutiérrez, M.; Bianchini, M. 2017: Guidelines for molecular monitoring of BCR-ABL1 in chronic myeloid leukemia patients by RT-qPCR Medicina 77(1): 61-72
Cervantes, F.; Colomer, D.; Vives-Corrons, J.L.; Rozman, C.; Montserrat, E. 1996: Chronic myeloid leukemia of thrombocythemic onset: a CML subtype with distinct hematological and molecular features? Leukemia 10(7): 1241-1243
Mattei, D.; Saglio, G.; Gottardi, E.; Gallamini, A.; Mordini, N.; Bacigalupo, A. 2001: Persisting molecular remission ten years after donor lymphocyte infusion for hematologic relapse in chronic myeloid leukemia Haematologica 86(5): 545-546
Grossman, A.; Mathew, A.; O'Connell, M.P.; Tiso, P.; Distenfeld, A.; Benn, P. 1990: Multiple restriction enzyme digests are required to rule out polymorphism in the molecular diagnosis of chronic myeloid leukemia Leukemia 4(1): 63-64
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Bhisey, A.N.; Khare, A.G.; Advani, S.H.; Ranadive, K.J. 1978: Cytogenetic studies in leukemias--blastic crisis of chronic myeloid leukemia Indian Journal of Medical Research 68: 285-294
Sacha, T.; Czekalska, S.; Foryciarz, K.; Zawada, M.; Florek, I.; Cwynar, D.; Wator, G.; Balwierz, W.; Skotnicki, A.B. 2011: H-oCT1 gene expression as a predictor of major and complete molecular response to imatinib of chronic myeloid leukemia. Single center experience Przeglad Lekarski 68(4): 191-195
Casado, L.F.; Picó, M.; Gómez, C.; Ferro, M.T.; Fernández-Rañada, J.M.; Steegmann, J.L. 1997: Fluctuating molecular remission in patients with chronic myeloid leukemia with long term complete cytogenetic response after alpha interferon treatment Medicina Clinica 109(7): 251-255
Udomsakdi-Auewarakul, C.; U-Pratya, Y.; Boonmoh, S.; Vatanavicharn, S. 2000: Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR) Journal of the Medical Association of Thailand 83(8): 928-935
Usui, N. 2004: Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia Rinsho Byori. Japanese Journal of Clinical Pathology 52(2): 136-144